- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07575178
Obstacle Course Versus Neuromotor Task Training in Children With DCD
Comparison of Obstacle Course Training and Neuromotor Task Training on Motor Planning and Functional Mobility in Children With Developmental Coordination Disorder
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Developmental Coordination Disorder (DCD) is a prevalent neurodevelopmental disorder affecting approximately 5-6% of school-aged children worldwide. Marked by impairments in motor coordination, skill development, and functional performance. The complex etiology of Developmental Coordination Disorder (DCD) is linked to atypical neurodevelopment, genetic predispositions, and associated co-morbidities such as ADHD and ASD, further influenced by perinatal factors like prematurity and low birth weight. DCD is associated with long-term consequences, including difficulties in activities of daily living (ADLs), reduced participation in physical activities, and impaired psychosocial functioning, which collectively increase the risk of obesity and lower self-efficacy. Early, targeted, and task-specific interventions are crucial. Among these, Neuromotor Task Training (NTT) focuses on improving motor planning through structured, cognitive strategies, while Obstacle Course Training (OCT) provides a dynamic setting that promotes functional movement and real-time problem-solving.
This randomized clinical trial will compare the effects of both interventions. The study will be conducted over 10 months at the University of Lahore Teaching Hospital (ULTH) pediatric rehabilitation center and Sehat Medical Complex (SMC) Hanjarwal. The duration of the intervention will be 9 weeks, with 2 sessions per week. There will be two study groups, and convenient sampling techniques will be used. Eligible participants will be children aged 7 to 10 years, both males and females, diagnosed with DCD based on DSM-5 criteria, with a Mini-Mental State Examination (MMSE) score >24 and an IQ above 75 on the Raven Intelligence Scale. Screening for DCD will be done using the Developmental Coordination Disorder Questionnaire (DCDQ) and motor proficiency will be assessed using the Bruininks-Oseretsky Test of Motor Proficiency (BOT-2). Children with a DCDQ score of ≤48 and a BOT-2 score of ≤40 will be included. Children with other neurological, psychiatric, or orthopedic conditions will be excluded. Participants will be randomly assigned to receive either Obstacle Course Training (OCT) or Neuromotor Task Training (NTT) to assess which intervention more effectively improves motor planning and functional mobility. SPSS version 27 will be used for data analysis.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Khadija Liaquat MS-NMPT
- Telefoonnummer: 03334956854
- E-mail: khadijaliaquat90@gmail.com
Studie Contact Back-up
- Naam: Imran Amjad Phd, MS
- Telefoonnummer: 03324390125
- E-mail: imran.amjad@riphah.edu.pk
Studie Locaties
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Nog niet aan het werven
- Riphah Rehabilitation Center, Riphah International University
-
Contact:
- Imran Amjad Phd
- Telefoonnummer: 03324390125
- E-mail: imran.amjad@riphah.edu.pk
-
Contact:
- Khadija Liaquat MS-NMPT
- Telefoonnummer: 03334956854
- E-mail: khadijaliaquat90@gmail.com
-
Lahore, Punjab Province, Pakistan, 54000
- Werving
- University Of Lahore Teaching Hospital ULTH
-
Contact:
- Imran Amjad Phd, Phd
- Telefoonnummer: 033224390125
- E-mail: imranamjad@riphah.edu.pk
-
Contact:
- khadija Liaquat, MS-PT
- Telefoonnummer: 03334956854
- E-mail: khadijaliaquat90@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
• Diagnosis of DCD based on DSM4/5 criteria.
- Children aged 7-10.
- Gender male and female.
- Mini-Mental State Examination (MMSE) score >24 .
- Cognitive development appropriate for chronological age.
- Raven Intelligence Test Scale (IQ > 75) .
- Developmental Coordination Questionnaire ≤48 points: likely DCD (≤ 10th percentile).
- BOT-2 score ≤ 40.
Exclusion Criteria:
- History of surgery and lower limb injuries over the past 12 months.
- Use of assistive devices to balance and walk.
- Severe ADHD, Autism Spectrum Disorder (if it significantly interferes with participation), or major psychiatric disorders.
- Taking neuroleptics or any other medications that significantly alter muscle tone, coordination, or attention.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Obstacle Course Training (OCT)
Participants will receive structured Obstacle Course Training focused on over-ground walking with obstacle negotiation.
Training targets motor planning, toe clearance, and functional mobility under single- and dual-task conditions.
|
Participants will perform Obstacle Course Training on a 12-meter walkway with a midpoint obstacle at low (30% leg length) and high (50% leg length) heights.
Training includes single-task walking (8 trials) and dual-task walking (16 trials) with concurrent visual discrimination tasks using flashcards.
Walking time, toe clearance, and response accuracy will be recorded.
Sessions will be conducted twice weekly for 9 weeks.
|
|
Experimenteel: Neuromotor Task Training (NTT)
Participants will receive neuromotor task training using task-oriented activities focused on motor planning, execution, and evaluation through structured, game-based stations.
|
Each session will involve task-oriented activities arranged in multiple stations. Activities will be broken down into planning, execution, and evaluation phases and will include soccer, netball, basketball, tagging games, rope skipping, and other age-appropriate functional games. Children will perform tasks with therapist guidance and feedback to enhance motor planning and performance. Each session will last approximately 45-60 minutes, including warm-up, main activities, and cool-down. The intervention will be delivered over 9 weeks, with 2 sessions per week. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) for fine and gross Motor Skills
Tijdsspanne: 9 weeks
|
The BOT-2 (Bruininks-Oseretsky Test of Motor Proficiency, Second Edition) scoring converts raw scores into precise motor proficiency metrics for ages 4-21, using sex-specific norms
|
9 weeks
|
|
Timed Up and Go Test (TUG)
Tijdsspanne: 9 weeks
|
The Timed Up and Go (TUG) test measures functional mobility and fall risk in seconds.
The test requires a participant to stand up, walk 3 meters, turn, walk back, and sit down.
Results < 10 seconds indicate normal mobility, while times >13.5-14
seconds indicate a higher risk of falls and frailty, requiring further evaluation
|
9 weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Arshmaan Mahmood, MS-PPT, Riphah International University
Publicaties en nuttige links
Algemene publicaties
- 1. Fogel Y, Stuart N, Joyce T, Barnett AL. Relationships between motor skills and executive functions in developmental coordination disorder (DCD): A systematic review. Scandinavian Journal of Occupational Therapy. 2023;30(3):344-56. 2. Castellucci G, Singla R. Developmental Coordination Disorder (Dyspraxia). StatPearls [Internet]: StatPearls Publishing; 2024. 3. Karabak M, Akıncı MA, Yıldırım Demirdöğen E, Bozkurt A. Prevalence and associated factors of developmental coordination disorder in primary school children. European Child & Adolescent Psychiatry. 2024:1-12. 4. Li H, Ke X, Huang D, Xu X, Tian H, Gao J, et al. The prevalence of developmental coordination disorder in children: a systematic review and meta-analysis. Frontiers in Pediatrics. 2024;12:1387406.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RCR&AHS/25/0708/Arshmaan
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .